Arterial Hypertension clinical trials

Explore recruiting arterial hypertension clinical trials.

Recruiting arterial hypertension studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Arterial Hypertension trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

IMPAHCT-FUL: A Long-Term Extension, Multi-Center Safety Study of AV-101 in Subjects With Pulmonary Arterial Hypertension (PAH) Who Have Completed Study AV-101-002

Portugal, Italy, Sweden, Czechia, Ireland, France +8 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Greek multicenter, single-arm, low-intervention clinical trial to evaluate the efficacy and safety of irbesartan/amlodipine fixed combination in newly diagnosed patients or patients with uncontrolled arterial hypertension.

Greece

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2b, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants with Pulmonary Arterial Hypertension

Belgium, Italy, Spain, Denmark, Austria, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

IMPAHCT: A Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled, 24-Week Dose Ranging and Confirmatory Study to Evaluate the Safety and Efficacy of AV-101 in Patients with Pulmonary Arterial Hypertension (PAH)

Czechia, Ireland, Poland, Latvia, Portugal, Greece +8 more

Phase II and Phase III (Integrated) EU CTIS Study details

Effects of single-pill combination of telmisartan/amlodipine and telmisartan/amlodipine/hydrochlorothiazide on 24-hour blood pressure (BP) reduction, 24-h BP variability and office BP control in patients with arterial hypertension – SATELLITE

Slovenia, Hungary, Poland

Phase III and phase IV (Integrated) EU CTIS Study details

Effects of DAPAgliflozin on cardiopulmonary exercise capacity and hemodynamics in Pulmonary Arterial Hypertension: A double blind randomized trial. (DAPAH-trial)

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Arterial Hypertension trials by city

Arterial Hypertension in Toronto Arterial Hypertension in Vancouver Arterial Hypertension in Montreal Arterial Hypertension in Calgary Arterial Hypertension in Edmonton Arterial Hypertension in Ottawa Arterial Hypertension in Winnipeg Arterial Hypertension in Quebec City Arterial Hypertension in Hamilton Arterial Hypertension in Kitchener Arterial Hypertension in London Arterial Hypertension in Halifax Arterial Hypertension in New York Arterial Hypertension in Los Angeles Arterial Hypertension in Chicago Arterial Hypertension in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease